GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent: Cross-Presentation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002480 describes the TAP-independent route by which antigen-presenting cells load exogenous peptide antigens onto classical MHC class I molecules for CD8+ T cell recognition.
• This pathway is a form of cross-presentation and operates independently of the transporter associated with antigen processing (TAP), distinguishing it from the canonical endogenous MHC class I pathway.
• Exogenous antigens can be internalized by carrier-mediated uptake or phagocytosis and then gain access to MHC class I loading compartments through secretory or endosomal routes.
• Interferon-gamma activation of macrophages can redirect exogenous antigen presentation toward a secretory pathway that is independent of TAP.
• TAP-independent cross-presentation is relevant to vaccine design, antitumor immunity, and host defense against pathogens such as Plasmodium and hepatitis C virus.
• Experimental dissection of GO:0002480 requires tools that separate TAP-dependent from TAP-independent antigen handling, including knockout and knock-in cell models.
Description
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480) is a specialized biological process in which an antigen-presenting cell expresses a peptide derived from an exogenous protein on its surface in association with a classical MHC class I complex, using an intracellular transport route that does not require TAP. This process is a molecularly defined form of cross-presentation and is central to how CD8+ T cells can be primed against antigens that are not synthesized within the presenting cell. Because it bypasses the canonical TAP-dependent pathway, GO:0002480 represents an alternative route for loading exogenous peptides onto MHC class I molecules. Researchers study this term to understand how vaccines, pathogens, and tumors can elicit cytotoxic T lymphocyte responses when TAP function is limited or evaded. The pathway has been linked experimentally to carrier-mediated peptide uptake, secretory presentation in activated macrophages, and virosome-based vaccine strategies. Defining the exact cellular compartments and molecular players involved remains an active area because TAP-independent presentation can shape the breadth and quality of CD8+ T cell immunity.
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent At A Glance
| GO ID | GO:0002480 |
|---|---|
| GO term | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
| Ontology | biological_process |
| Synonym | cross presentation; cross-presentation; exogenous peptide antigen processing and presentation via MHC class I, TAP-independent; TAP-independent antigen processing and presentation of exogenous peptide antigen via MHC class I; TAP-independent exogenous peptide antigen processing and presentation via MHC class I |
| Major function | Presentation of exogenous peptide antigens on classical MHC class I molecules without requiring TAP |
| Cellular context | Antigen-presenting cells including dendritic cells and macrophages |
| Pathway relationship | Alternative to the canonical TAP-dependent MHC class I antigen presentation pathway |
| Key distinction | Exogenous antigen origin and TAP-independent intracellular transport |
What Is GO:0002480?
GO:0002480 is defined as the process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein that has been degraded within the cell, and class I here refers to classical class I molecules. In other words, it is TAP-independent cross-presentation of exogenous peptide antigen via MHC class I.
Why Is antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Important in Cell Biology?
GO:0002480 matters because it defines a route by which exogenous antigens, including vaccine antigens and pathogen-derived proteins, can be presented on MHC class I to activate CD8+ cytotoxic T lymphocytes without relying on TAP. This has direct implications for vaccine design, antitumor immunity, and infections in which TAP function is impaired or actively evaded by pathogens. Understanding TAP-independent cross-presentation also helps explain how adjuvants and delivery systems, such as TLR2 ligands or virosomes, can enhance class I-restricted immune responses.
• Provides an alternative MHC class I loading route when TAP function is limited or evaded by viruses.
• Supports cross-presentation of exogenous antigens to CD8+ T cells, a key step in cytotoxic T lymphocyte priming.
• Relevant to vaccine platforms that deliver exogenous peptides or proteins for class I presentation.
• Linked to TLR2-mediated mechanisms of antigen cross-presentation in dendritic cells.
• Implicated in protection induced by radiation-attenuated Plasmodium sporozoites, where TAP-mediated processing of exoerythrocytic antigens is essential.
• Can be studied using carrier-mediated peptide uptake systems that deliver exogenous peptides into MHC class I presentation pathways.
• Interferon-gamma activation of macrophages can shift exogenous antigen presentation toward a secretory, TAP-independent route.
• Relevant to hepatitis C virus vaccine development using non-live virosome prototypes.
• Helps interpret differences between TAP-dependent and TAP-independent antigen handling in disease models.
• Guides design of multiepitope vaccines intended to induce both CTL and Th immune responses.
What Happens During antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent?
Uptake of exogenous antigen
In simple terms: The cell first takes in material from outside itself.
The process begins when an antigen-presenting cell internalizes exogenous antigen. Carrier-mediated uptake can deliver MHC class I-restricted peptides into the cell, providing a route for exogenous peptide entry. This uptake step is a prerequisite for subsequent processing and presentation on classical MHC class I molecules.
Intracellular degradation and peptide generation
In simple terms: Inside the cell, larger proteins are cut into smaller peptide pieces.
Once internalized, exogenous proteins are degraded within the cell to generate peptide fragments. The QuickGO definition specifies that the peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. This degradation step supplies the peptides that will later be loaded onto MHC class I molecules.
TAP-independent intracellular transport
In simple terms: The peptides reach MHC class I molecules without using the usual TAP transporter.
A defining feature of GO:0002480 is that intracellular transport of the peptide to the MHC class I loading site does not require TAP. This distinguishes the pathway from the canonical TAP-dependent route and allows presentation to proceed when TAP is bypassed or impaired. The existence of TAP-independent routes is one reason viral immune evasion strategies that target TAP do not completely abolish class I presentation.
Secretory pathway presentation in activated macrophages
In simple terms: Activated immune cells can send antigens out through a secretion-like route.
Macrophages activated by interferon-gamma can present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway. This secretory route represents a TAP-independent mechanism by which exogenous antigen gains access to MHC class I presentation. It highlights how the activation state of the antigen-presenting cell can influence which presentation pathway is used.
MHC class I surface expression and CD8+ T cell recognition
In simple terms: The peptide is displayed on the cell surface for immune cells to see.
The final outcome is expression of the exogenous peptide antigen on the cell surface in association with a classical MHC class I protein complex. This surface display enables recognition by CD8+ T cells and is the functional endpoint of GO:0002480. Cross-presentation via this TAP-independent route can thereby contribute to cytotoxic T lymphocyte activation.
Key Genes Involved in GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent
The following genes and proteins are experimentally implicated in TAP-independent MHC class I antigen processing and presentation of exogenous antigens.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TAP1 | Transporter associated with antigen processing subunit 1 | Defines the TAP-dependent pathway that GO:0002480 bypasses; key comparator in knockout studies |
| TAP2 | Transporter associated with antigen processing subunit 2 | Partner of TAP1; loss-of-function helps isolate TAP-independent presentation |
| HLA-A | Classical MHC class I heavy chain | Presents exogenous peptides on the cell surface in GO:0002480 |
| HLA-B | Classical MHC class I heavy chain | Alternative classical class I molecule for exogenous peptide display |
| HLA-C | Classical MHC class I heavy chain | Contributes to classical class I antigen presentation |
| B2M | Beta-2-microglobulin, MHC class I light chain | Required for stable MHC class I surface expression |
| TLR2 | Toll-like receptor 2 | Mediates signaling that promotes antigen cross-presentation in dendritic cells |
| IFNG | Interferon gamma | Activates macrophages and shifts exogenous antigen presentation to a secretory pathway |
| CD8A | CD8 alpha chain | Defines cytotoxic T cells that recognize MHC class I-peptide complexes |
| CD8B | CD8 beta chain | Partners with CD8A in MHC class I co-receptor function |
| CANX | Calnexin | MHC class I assembly chaperone relevant to class I biogenesis |
| CALR | Calreticulin | MHC class I assembly chaperone relevant to class I biogenesis |
| PDIA3 | Protein disulfide isomerase family A member 3 | MHC class I peptide-loading complex component |
| TAPBP | TAP binding protein (tapasin) | Peptide-loading complex component; helps distinguish TAP-dependent from TAP-independent routes |
| PSMB8 | Immunoproteasome subunit beta 8 | Contributes to peptide generation for class I presentation |
| PSMB9 | Immunoproteasome subunit beta 9 | Contributes to peptide generation for class I presentation |
| LAMP1 | Lysosomal-associated membrane protein 1 | Endosomal/lysosomal marker relevant to exogenous antigen handling |
How Is antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Regulated?
GO:0002480 is regulated by the activation state of the antigen-presenting cell and by innate immune signals. Interferon-gamma activation of macrophages can induce a secretory pathway for class I presentation of exogenous antigens, thereby influencing whether TAP-independent presentation occurs. TLR2-mediated signaling in dendritic cells promotes antigen cross-presentation, linking innate receptor engagement to enhanced class I presentation of exogenous antigen. Viral immune evasion proteins that target MHC class I antigen presentation also shape the selective pressure for TAP-independent routes. In addition, the availability of classical MHC class I molecules and their assembly components determines the capacity for surface display of exogenous peptides.
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TAP1 | Viral immune evasion and antigen presentation deficiency | TAP1 knockout cell line to isolate TAP-independent presentation |
| TAP2 | Antigen processing defects | TAP2 knockout dendritic cell model |
| IFNG | Macrophage activation and secretory antigen presentation | IFNG-stimulated macrophage presentation assay |
| TLR2 | Dendritic cell cross-presentation | TLR2 agonist-treated dendritic cell model |
| HLA-A | CD8+ T cell recognition of exogenous antigen | HLA-A knock-in or tagged knock-in reporter cells |
Viral immune evasion and TAP-independent presentation
Viruses encode proteins that interfere with MHC class I antigen presentation, including components of the TAP-dependent pathway. Because GO:0002480 operates without TAP, it provides an alternative route for class I presentation that may remain functional when viral evasion targets TAP. Studying this pathway helps explain how antiviral CD8+ T cell responses can persist despite viral immune evasion.
Plasmodium infection and vaccine-induced protection
TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites. This finding places TAP-dependent and TAP-independent antigen handling in the context of protective immunity against malaria. Understanding GO:0002480 helps interpret which antigen presentation routes contribute to CD8+ T cell-mediated protection.
Hepatitis C virus vaccine development
Core peptide-bearing immunopotentiating reconstituted influenza virosomes have been studied in vitro as a non-live prototype vaccine against hepatitis C virus. Such platforms deliver exogenous antigen and rely on class I presentation pathways, including cross-presentation, to induce cytotoxic T cell responses. GO:0002480 is relevant to interpreting how these vaccine prototypes achieve MHC class I-restricted presentation.
Antitumor immunity and multiepitope vaccines
Multiepitope Trojan antigen peptide vaccines have been designed to induce antitumor CTL and Th immune responses. These vaccines depend on efficient presentation of exogenous peptides to CD8+ T cells, a process related to cross-presentation. TAP-independent presentation pathways may contribute to the immunogenicity of such constructs.
From antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene control TAP-independent cross-presentation? | Knockout cell model with TAP1 or TAP2 deletion |
| Does a specific MHC class I allele present a defined exogenous peptide? | Point-mutation or knock-in of HLA allele |
| Where does the exogenous peptide encounter MHC class I? | Tagged knock-in of MHC class I or endosomal markers |
| Can overexpression of a chaperone enhance TAP-independent presentation? | Overexpression cell model for MHC class I assembly components |
| Does TLR2 signaling enhance cross-presentation? | TLR2 agonist-treated dendritic cell model |
| Does interferon-gamma shift presentation to a secretory route? | IFNG-stimulated macrophage model |
How to Study the antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Process
| Method | What It Measures | Typical Application |
|---|---|---|
| MHC class I surface staining | Surface expression of peptide-MHC class I complexes | Detect exogenous peptide presentation |
| T cell activation assay | Recognition of presented antigen by CD8+ T cells | Functional readout of cross-presentation |
| Flow cytometry | Quantification of MHC class I and antigen uptake | Compare TAP-deficient and TAP-competent cells |
| Confocal imaging | Intracellular localization of antigen and MHC class I | Trace secretory presentation route |
| CRISPR knockout | Requirement of candidate genes | Test TAP1/TAP2 dependence |
| CRISPR knock-in | Tagged MHC class I tracking | Monitor peptide loading and surface delivery |
| TLR2 agonist treatment | Innate signaling effect on cross-presentation | Dendritic cell cross-presentation studies |
| Virosome vaccine assay | Class I-restricted presentation of exogenous antigen | Hepatitis C virus vaccine prototype testing |
Antigen presentation assays
Functional assays measure surface display of exogenous peptide in association with classical MHC class I molecules, often using specific antibodies or T cell hybridomas. These assays are the primary readout for GO:0002480 activity. Comparing TAP-deficient and TAP-competent cells helps isolate the TAP-independent component.
Flow cytometry and imaging
Flow cytometry can quantify MHC class I surface levels and peptide loading in antigen-presenting cells. Imaging approaches can track intracellular transport of exogenous antigen and its colocalization with MHC class I compartments. These methods help define the secretory route observed in interferon-gamma-activated macrophages.
Genetic perturbation with CRISPR
CRISPR knockout of TAP1, TAP2, or MHC class I assembly genes allows researchers to test which components are required for TAP-independent presentation. Knock-in of tagged MHC class I alleles enables tracking of peptide loading and surface delivery. These perturbations help distinguish GO:0002480 from TAP-dependent pathways.
Vaccine and adjuvant models
Virosome and peptide vaccine platforms provide experimental systems to test whether exogenous antigens are presented via class I pathways. TLR2 agonists can be used to probe innate signaling effects on cross-presentation. Radiation-attenuated Plasmodium sporozoite models link TAP-dependent processing to protective immunity.
How CRISPR Can Be Used to Study GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent
Knockout
CRISPR knockout of TAP1 or TAP2 creates cell models in which the canonical TAP-dependent pathway is disabled, allowing the TAP-independent route defined by GO:0002480 to be studied in isolation. Knockout of MHC class I assembly genes such as B2M can confirm the requirement for classical class I molecules in exogenous peptide presentation. These models are essential for attributing observed presentation to GO:0002480 rather than to TAP-dependent mechanisms.
Point Mutation
Point mutations in MHC class I genes or in antigen processing components can be introduced to test which residues are required for TAP-independent presentation. Such models help dissect whether a specific molecular feature supports exogenous peptide loading. They are particularly useful when a complete knockout would be lethal or would confound interpretation.
Knock-in
Knock-in of tagged MHC class I alleles or tagged endosomal markers enables tracking of exogenous peptide transport and surface delivery in live or fixed cells. Tagged knock-in models can reveal the secretory route used by interferon-gamma-activated macrophages. They also allow direct comparison of TAP-dependent and TAP-independent loading events.
Overexpression
Overexpression of MHC class I assembly components or candidate chaperones can test whether increasing their levels enhances TAP-independent presentation. Overexpression models are useful for probing rate-limiting steps in exogenous peptide loading. They can also be combined with TLR2 agonist treatment to test synergy with innate signaling.
How EDITGENE Supports antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Research
Researchers studying antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent-related genes often need to determine whether a candidate gene is causally involved in exogenous peptide presentation or is merely correlated with it. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causation in this pathway.
Contact EDITGENE today to design your custom CRISPR model for antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent research.
Frequently Asked Questions About antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent
What is GO:0002480?
GO:0002480 is the Gene Ontology term for antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent, a form of cross-presentation that does not require the TAP transporter.
What does TAP-independent mean in antigen presentation?
TAP-independent means the peptide reaches MHC class I molecules through an intracellular route that does not use the transporter associated with antigen processing.
What genes are involved in TAP-independent cross-presentation?
Genes implicated include TAP1, TAP2, classical MHC class I genes such as HLA-A, B2M, IFNG, and TLR2, among others.
How is TAP-independent presentation different from the canonical MHC class I pathway?
The canonical pathway relies on TAP to transport peptides into the endoplasmic reticulum, whereas GO:0002480 uses a TAP-independent intracellular transport route for exogenous peptides.
Why is cross-presentation important for vaccines?
Cross-presentation allows exogenous vaccine antigens to be presented on MHC class I and activate CD8+ cytotoxic T cells, which is important for antitumor and antiviral immunity.
Can macrophages present exogenous antigen via MHC class I without TAP?
Yes, interferon-gamma-activated macrophages can present exogenous antigens by class I MHC molecules via a secretory pathway.
What role does TLR2 play in cross-presentation?
TLR2-mediated signaling in dendritic cells promotes antigen cross-presentation, linking innate immune activation to enhanced class I presentation.
Is TAP-mediated processing always required for protective immunity?
No; TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites, but other contexts can use TAP-independent routes.
How can I study GO:0002480 in the lab?
Researchers use antigen presentation assays, flow cytometry, imaging, and CRISPR knockout or knock-in models to study TAP-independent presentation.
What experimental models are available for TAP-independent antigen presentation?
Knockout, point-mutation, knock-in, tagged knock-in, and overexpression cell models can be used to dissect the pathway.
Conclusion
GO:0002480 defines a TAP-independent route for presenting exogenous peptide antigens on classical MHC class I molecules, a process central to cross-presentation and CD8+ T cell activation. Its relevance spans viral immune evasion, malaria vaccine-induced protection, hepatitis C vaccine prototypes, and antitumor immunity. Studying this pathway with precise CRISPR models helps clarify how exogenous antigens reach MHC class I when TAP is bypassed or impaired.
References
- 1. van de Weijer ML et al.. 2015. Viral immune evasion: Lessons in MHC class I antigen presentation.. Semin Immunol 27(2):125-37 PMID: 25887630
- 2. Shen KY et al.. 2014. Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.. J Immunol 192(9):4233-41 PMID: 24683188
- 3. Pichugin A et al.. 2016. TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites.. Eur J Immunol 46(4):885-96 PMID: 26703789
- 4. Brander C et al.. 1993. Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptide.. Eur J Immunol 23(12):3217-23 PMID: 8258336
- 5. Lu J et al.. 2004. Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.. J Immunol 172(7):4575-82 PMID: 15034075
- 6. Martín-Orozco N et al.. 2001. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.. Immunology 103(1):41-8 PMID: 11380691
- 7. Hunziker IP et al.. 2002. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.. Int Immunol 14(6):615-26 PMID: 12039913
